查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球医用聚合物市场（按类型、製造技术、应用和地区划分）—预测至2030年
市场调查报告书
商品编码
1811735

全球医用聚合物市场（按类型、製造技术、应用和地区划分）—预测至2030年

Medical Polymer Market by Type (Medical Plastics, Medical Elastomers), Application (Medical Disposables, Medical Instruments and Devices, Prosthetics, Diagnostics Instruments and Tools), Manufacturing Technology, and Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 451 Pages | 订单完成后即时交付

价格

预计医用聚合物市场将从 2025 年的 447 亿美元成长到 2030 年的 662.9 亿美元，预测期内的复合年增长率为 8.2%。

随着医疗保健、材料工程和以患者为中心的创新的不断进步，医用聚合物市场正在快速成长。关键驱动因素包括对轻质、耐用且适用于生物相容性材料（例如植入、导管、诊断设备甚至手术器械）的需求。

调查范围
调查年份 2022-2030
基准年 2024
预测期 2025-2030
对价单位 金额（百万美元）、数量（千吨）
部分 按类型、製造技术、应用和地区
目标区域 北美、欧洲、亚太地区、南美、中东和非洲

慢性病的增加、人口老化以及对微创手术的需求，促使人们对具有灵活性、安全性和精确性的先进聚合物偏好。尽可能向卫生和无污染的一次性医疗产品的重大转变也促进了聚合物部件的广泛采用。聚合物科学正在不断发展，以创造出具有优异机械强度、耐用性、抗菌性能以及与主动灭菌技术相容性的聚合物和材料。知识和发展的进步带来了形状保持聚合物或生物可吸收聚合物的突破，为药物传输装置和组织工程创造了机会。医疗 3D 列印的广泛使用透过快速开发客製化设计的植入和器械彻底改变了这一领域。此外，人们对永续性的日益关注导致人们对可回收和可生物降解聚合物的兴趣日益浓厚。

医用聚合物市场-IMG1

医用弹性体是医用聚合物市场的第二大类别，这得益于其独特的性能组合，包括柔韧性、耐用性和生物相容性，使其能够用于数百种满足关键医疗保健需求的精密应用。许多医用弹性体应用涉及含有液体或需要持续运动、拉伸或压缩的产品，例如密封件、垫圈、导管、注射器、柱塞和导管组件。医用弹性体产品以其耐化学腐蚀、耐温度变化和耐灭菌技术而闻名，能够在高应力医疗应用中提供可靠的产品。文献中经常引用硅橡胶、热可塑性橡胶(TPE) 和橡胶材料，因为它们比传统和刚性聚合物具有更高的舒适度，使其成为穿戴式医疗设备和皮肤接触应用的首选。此外，最小化持续推动弹性体材料性能的提升，影响药物传输系统、自动封装和检测系统以及生活方式诊断设备的先进设计方面也发挥着重要作用。此外，弹性体材料特别适合自动化生产和成型，其弹性模量和拉伸强度较低，从而能够实现经济高效的大量生产。再加上对现代医疗保健创新和安全的支持和推动，这些因素最终促使医用弹性体成为医用聚合物市场中一个快速成长且至关重要的类别。

抛弃式医疗用品是医用聚合物市场的第二大应用，因为它们在维护医疗环境中的清洁度、病人安全和感染控制方面非常重要。注射器、手套、静脉输液袋、管路和连接器、外科用覆盖巾和口罩都是一次性使用的，以防止交叉污染并维持无菌环境。由于对感染预防和支持感染控制的法规的重视，对一次性医疗用品的需求正在增长。聚丙烯、聚乙烯和聚氯乙烯是用于一次性医疗用品的主要聚合物，因为它们具有出色的加工性、低成本以及与灭菌製程的兼容性。住院时间的增加、外科手术的增加以及门诊病人的增加正在推动对高品质抛弃式的需求，尤其是在新兴地区。即用型无菌物品的便利性提高了繁忙的医疗环境中的效率。随着医疗保健继续强调安全性、成本效益和效率，预计聚合物一次性医疗用品仍将是关键的成长领域。

射出成型是医用聚合物领域第二大製造技术，因为它能够可靠且有效率地大规模生产高精度、复杂的零件。射出成型用于製造各种各样的医疗产品，包括诊断设备外壳、手术器械手柄、注射器、连接器和植入式设备组件。射出成型与许多医用级聚合物相容，包括聚碳酸酯、聚丙烯和ABS。它可以生产需要强度、生物相容性、耐化学性和清洗的零件。射出成型射出成型可以製造具有严格公差的复杂形状，所有这些都与满足医疗设备业的安全和性能要求有关。射出成型也易于自动化，从而可以经济高效地批量生产高品质产品。多色注塑和微加工技术的最新进展进一步拓宽了其应用范围。这些优势凸显了射出成型在医用聚合物市场中的重要作用，支持产品创新并持续满足对精密、可靠医疗产品的需求。

北美是医用聚合物市场成长第二快的地区，主要得益于强劲的医疗保健动态和创新需求。美国不断扩大的保险覆盖范围以及加拿大强劲的公共和私人医疗保健投资，正在推动人均医疗保健支出的成长。在医疗保健进步的推动下，预计北美在医疗设备、包装和创伤护理类别中的成长将超过其他任何地区。然而，美国拥有世界上最具创新性的医疗保健环境之一，这得益于发达的医疗保健基础设施、强大的研发 (R&D) 生态系统以及与聚合物产业的牢固伙伴关係。这导致了各种高性能聚合物的创造和扩展。其中许多聚合物为手术器械、诊断和药物传输系统提供生物相容性甚至生物降解性（树脂和纤维）。医疗保健产业依赖新产品设计和创新概念，以利用新产品开发（例如 PEEK 和其他工程塑胶）来成功推出符合患者偏好的产品，例如一次性用品、微创设备和居家照护。虽然亚太地区以最高的复合年增长率领先，但北美是成长第二快的地区。这得益于其强大的监管环境（以及美国的监管创新）、成熟的医疗保健体系，以及服务于患者和医疗保健产业的关键聚合物製造商，同时又不牺牲聚合物技术开发的创新。

本报告研究了全球医用聚合物市场，按类型、製造技术、应用和地区进行细分，并提供了参与市场的公司概况。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章 市场概况

  • 介绍
  • 市场动态
  • 波特五力分析
  • 总体经济指标

第六章 产业趋势

  • 介绍
  • 主要相关人员和采购标准
  • 价值链分析
  • 生态系分析
  • 案例研究分析
  • 监管状况
  • 技术分析
  • 影响客户业务的趋势/中断
  • 贸易分析
  • 2025-2026年主要会议和活动
  • 定价分析
  • 投资金筹措场景
  • 专利分析
  • 人工智慧/生成式人工智慧对医用聚合物市场的影响
  • 2025年美国关税对医用聚合物市场的影响

第七章医用聚合物市场（按类型）

  • 介绍
  • 医用塑料
  • 医用弹性体
  • 其他的

8. 医用聚合物市场（依製造技术）

  • 介绍
  • 挤压管
  • 压缩成型
  • 射出成型
  • 其他的

第九章医用聚合物市场（依应用）

  • 介绍
  • 医疗抛弃式
  • 医疗设备
  • 义肢
  • 诊断设备和工具
  • 其他的

第 10 章医用聚合物市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 其他的
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的

第十一章 竞争格局

  • 概述
  • 主要参与企业的策略
  • 2022-2024年收益分析
  • 2024年市场占有率分析
  • 估值和财务指标
  • 品牌/产品比较分析
  • 公司估值矩阵：2024 年关键参与企业
  • 公司估值矩阵：Start-Ups/中小企业，2024 年
  • 竞争场景

第十二章：公司简介

  • 主要参与企业
    • BASF
    • SABIC
    • COVESTRO AG
    • CELANESE CORPORATION
    • EVONIK INDUSTRIES
    • ARKEMA
    • SOLVAY
    • KURARAY CO., LTD.
    • MOMENTIVE PERFORMANCE MATERIALS INC.
    • DUPONT
  • 其他公司
    • TRINSEO
    • KRATON CORPORATION
    • TOTAL PLASTICS
    • SIMONA AMERICA
    • DSM
    • INVIBIO
    • AVIENT CORPORATION
    • RTP COMPANY
    • TEKNIPLEX
    • TEKNOR APEX
    • MITSUBISHI CHEMICALS ADVANCED MATERIALS
    • WACKER CHIMIE
    • HARDIE POLYMERS
    • ELIX POLYMERS
    • INNOVATIVE POLYMER COMPOUNDS

第十三章 附录

Product Code: CH 9017

The medical polymer market is projected to reach USD 66.29 billion by 2030 from USD 44.70 billion in 2025, at a CAGR of 8.2% during the forecast period. The medical polymer market is experiencing rapid growth as a result of continual progress in healthcare, materials engineering, and patient-focused innovation. Major factors driving include need for materials that are lightweight, durable, and suitable for use in situations involving biocompatible materials, like implants or catheters, diagnostic equipment, and even surgical instruments.

Scope of the Report
Years Considered for the Study2022-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Million), Volume (Kiloton)
SegmentsType, Application, Manufacturing Technology, and Region
Regions coveredNorth America, Europe, Asia Pacific, South America, and Middle East & Africa

The increased prevalence of chronic diseases, aging population, and the need for minimally invasive procedures is creating preference for advanced polymers that provide flexibility, security, and accuracy. The considerable shift in the use of disposable medical products, where possible, for sanitation and fewer contaminants has contributed to the proliferation of components made from polymers. The science of polymers is advancing to create polymers and materials with superior mechanical strength, durability, antimicrobial properties, and compatibility with active-sterilization techniques. Advances in knowledge and developments have resulted in breakthroughs in polymers that can hold shapes, or bioresorbable, that offer opportunities in the areas of drug delivery devices and tissue engineering. Proliferation of medical-grade 3D printing has revolutionized this area because custom-designed implants and devices can now be developed rapidly. There has increased attention on sustainable practices, leading to interest in recyclable and biodegradable polymers.

Medical Polymer Market - IMG1

"Medical elastomers to account for the second-largest type in the medical polymer market during the forecast period."

Medical elastomers account for the second-largest type in the medical polymer market based on unique combinations of characteristics, such as flexibility, durability, and biocompatibility, allowing them to be used for hundreds of precise applications for critical healthcare. Many of the devoted elastomer applications are products used to contain fluids or products that need to be manipulated with constant movement, stretching, or compression, like seals, gaskets, tubing, syringes, plungers, and catheter components. Medical elastomer products are best known because of their chemical resistance, resistance to temperature swings, and resistance to sterilization techniques, which enables reliable products in high-stress medical applications. Because silicone elastomers, thermoplastic elastomers (TPE), and rubber materials are often specifically mentioned in literature due to increased comfort above conventional or hard polymers, they are favored for wearable medical devices and skin-contact applications. In addition, the influence of minimization continues to drive performance elastomeric materials, as do the advanced design aspects influencing drug delivery systems, automated enclosed testing systems, and lifestyle diagnostic devices. Furthermore, elastomeric materials are especially amenable to automated manufacturing and/or molding with E-modulus and tensile strength decreases, enabling cost-effective production in considerably large amounts. Combined with supporting and allowing innovation and safety in modern healthcare, these ultimately contribute to the fast-growing and extremely important category of medical elastomers in the medical polymer market.

"Medical disposables to account for the second-largest share of the medical polymer market during the forecast period."

Medical disposables are the second-largest application in the medical polymer market because of their importance in cleanliness, patient safety, and infection control in healthcare settings. Items such as syringes, gloves, IV bags, tubing and connections, surgical drapes, and masks are designed for single-use to prevent cross-contamination and maintain sterile environments. The emphasis on infection prevention and regulations supporting infection control have increased demand for disposable medical items. Due to their excellent processability, low cost, and compatibility with sterilizing processes, the polymers used in medical disposables are primarily polypropylene, polyethylene, and PVC. The increase in hospital stays, enhanced surgical procedures, and outpatient care, especially in emerging regions, are driving demand for good quality disposables. Convenience of ready-to-use pre-sterilized items can add efficiency in busy medical settings. As healthcare continues to focus on safety, cost-effective practices, and efficiencies, polymer medical disposables will be an important future growth area going forward.

"Injection molding is projected to be the second-largest manufacturing technology in the medical polymer market during the forecast period."

Injection molding is the second-largest manufacturing technology in the medical polymer space because it can produce highly precise and complex components at scale with good reliability and efficiency. Injection molding is used to produce a wide variety of medical products, for example, housing for diagnostic equipment, surgical instrument handles, syringes, connectors, components of implantable devices, and so forth. Injection molding is compatible with many medical-grade polymers, for example, it can be made from polycarbonate, polypropylene, and ABS. With injection molding, the manufacture of components that must have strength, biocompatibility, chemical resistance, and washability is possible. Injection molding can be made to tight tolerances with complex geometries; all of which are relevant in meeting the safety and performance requirements of the medical device industry. Injection molding is also compatible with automation and is conducive to produce items in large volumes while being cost-effective along with high quality output. Recent advancements in multi-shot and micro fabrication further enhances the application range as well. With all of these advantages it is easy to see how injection molding plays a critical role in the medical polymer market which supports product innovations and continues to aid the demand for sophisticated and reliable medical products.

"North America is projected to be the second-fastest growing region in the medical polymer market during the forecast period."

North America is the second-fastest growing region in the medical polymer market, due largely to strong healthcare dynamics, and innovated demand. Per capita healthcare expenses are rising, initiated by expanding insurance coverage in the US and strong public and private healthcare investments in Canada. The medical devices, packaging, and wound care categories are projected to account for greater growth in North America than any other region as healthcare advances. However, the US has one of the most innovative healthcare environments in the world based on a developed healthcare infrastructure, a strong Research and Development (R&D) ecosystem, and a strong partnership with the polymer industry, leading to the creation of a broad and expanding array of high-performance polymers. Many of these polymers have properties that are biocompatible and even biodegradable (resins and fibers) for surgical devices, diagnostics, and drug delivery systems. The healthcare industry relies on new product designs and innovative ideas regarding the use of new products developments (e.g., PEEK and other engineering plastics), to ensure successful product introduction that will also meet patients' preferences for disposable, minimally invasive, and home care solutions. While the Asia Pacific region is leading with the highest CAGR, North America is the second-fastest growing region, due to its regulatory strength (and US regulation innovation), established healthcare system, and leading region with polymer manufacturers serving patients and the medical sector without sacrificing innovation in the development of polymer technologies.

Extensive interviews with experts were conducted to determine and verify the market size for several segments and subsegments and the information gathered through secondary research.

The break-up of interviews with experts is given below:

  • By Department: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
  • By Designation: C Level: 35%, Director Level: 30%, and Executives: 35%
  • By Region: North America: 25%, Europe: 45%, Asia Pacific: 20%, South America: 5%, Middle East & Africa 5%

BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others are some of the key players in the medical polymer market.

The study includes an in-depth competitive analysis of these key players in the medical polymer market, with their company profiles, recent developments, and key market strategies.

Research Coverage

The market study covers the medical polymer market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on type, application, manufacturing technology, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to enhance their positions in the medical polymer market.

Key Benefits of Buying the Report

The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical polymer market and its segments and subsegments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the positions of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing demand for biocompatible materials, Growing aging population globally, Advancements in medical technology, Regulatory support for medical-grade materials), restraints (Regulatory complexities and approvals, High competition from alternative materials, Environmental sustainability concerns), opportunities (Growth in regenerative medicine, Demand for minimally invasive devices, Advancements in biodegradable polymers), challenges (Cost constraints for novel materials, Long term durability and degradation control)
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product & service launches in the medical polymer market
  • Market Development: Comprehensive information about lucrative markets - the report analyzes the medical polymer market across varied regions

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical polymer market

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others are covered in the medical polymer market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 INCLUSIONS AND EXCLUSIONS
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 UNITS CONSIDERED
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of major secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 List of primary interview participants-demand and supply side
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 FORECAST NUMBER CALCULATION
  • 2.4 DATA TRIANGULATION
  • 2.5 FACTOR ANALYSIS
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 LIMITATIONS AND RISKS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL POLYMER MARKET
  • 4.2 MEDICAL POLYMER MARKET, BY TYPE
  • 4.3 MEDICAL POLYMER MARKET, BY APPLICATION
  • 4.4 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY
  • 4.5 MEDICAL POLYMER MARKET, BY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for biocompatible materials
      • 5.2.1.2 Surge in global aging population
      • 5.2.1.3 Advancements in medical technology
      • 5.2.1.4 Rise in chronic diseases
      • 5.2.1.5 Regulatory support for medical-grade materials
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Regulatory complexities and approvals
      • 5.2.2.2 High competition from alternative materials
      • 5.2.2.3 Environmental sustainability concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth in regenerative medicine
      • 5.2.3.2 Demand for minimally invasive devices
      • 5.2.3.3 Advancements in biodegradable polymers
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Cost constraints for novel materials
      • 5.2.4.2 Long-term durability and degradation control
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT FROM NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF BUYERS
    • 5.3.4 BARGAINING POWER OF SUPPLIERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 MACROECONOMIC INDICATORS
    • 5.4.1 GLOBAL GDP TRENDS

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 KEY STAKEHOLDERS & BUYING CRITERIA
    • 6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 6.2.2 BUYING CRITERIA
  • 6.3 VALUE CHAIN ANALYSIS
    • 6.3.1 RAW MATERIAL SUPPLIERS
    • 6.3.2 MANUFACTURERS
    • 6.3.3 DISTRIBUTORS
    • 6.3.4 END CONSUMERS
  • 6.4 ECOSYSTEM ANALYSIS
  • 6.5 CASE STUDY ANALYSIS
    • 6.5.1 EVONIK INDUSTRIES PROVIDES MEDICAL POLYMERS TO JENACELL GMBH FOR WOUND DRESSINGS, IMPLANTABLE MATERIALS, AND DRUG DELIVERY SYSTEMS
    • 6.5.2 ENSINGER OFFERS HIGH-PERFORMANCE, MEDICAL-GRADE POLYMERS FOR HIGH-FREQUENCY SURGERY
  • 6.6 REGULATORY LANDSCAPE
  • 6.7 TECHNOLOGY ANALYSIS
    • 6.7.1 KEY TECHNOLOGY
      • 6.7.1.1 Biocompatible polymers
      • 6.7.1.2 Thermoplastic elastomers
    • 6.7.2 COMPLEMENTARY TECHNOLOGY
      • 6.7.2.1 Thermoplastic elastomers
      • 6.7.2.2 Surface modification techniques
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 6.9 TRADE ANALYSIS
    • 6.9.1 IMPORT SCENARIO
    • 6.9.2 EXPORT SCENARIO
  • 6.10 KEY CONFERENCES & EVENTS, 2025-2026
  • 6.11 PRICING ANALYSIS
    • 6.11.1 AVERAGE SELLING PRICE TREND, BY REGION, 2022-2024
    • 6.11.2 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2022-2024
    • 6.11.3 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, BY APPLICATION, 2024
  • 6.12 INVESTMENT AND FUNDING SCENARIO
  • 6.13 PATENT ANALYSIS
    • 6.13.1 METHODOLOGY
    • 6.13.2 PATENTS GRANTED WORLDWIDE, 2015-2024
    • 6.13.3 PUBLICATION TRENDS
    • 6.13.4 INSIGHTS
    • 6.13.5 LEGAL STATUS OF PATENTS
    • 6.13.6 JURISDICTION ANALYSIS
    • 6.13.7 TOP APPLICANTS
  • 6.14 IMPACT OF AI/GEN AI ON MEDICAL POLYMER MARKET
  • 6.15 IMPACT OF 2025 US TARIFF ON MEDICAL POLYMER MARKET
    • 6.15.1 INTRODUCTION
    • 6.15.2 KEY TARIFF RATES
    • 6.15.3 PRICE IMPACT ANALYSIS
    • 6.15.4 IMPACT ON KEY COUNTRIES/REGIONS
      • 6.15.4.1 North America
      • 6.15.4.2 Europe
      • 6.15.4.3 Asia Pacific
    • 6.15.5 IMPACT ON END-USE INDUSTRIES

7 MEDICAL POLYMER MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 MEDICAL PLASTICS
    • 7.2.1 ADVANCEMENTS IN MATERIAL SCIENCE AND MANUFACTURING TECHNOLOGIES TO DRIVE MARKET
    • 7.2.2 POLYPROPYLENE
    • 7.2.3 POLYVINYL CHLORIDE
    • 7.2.4 POLYETHYLENE
    • 7.2.5 POLYSTYRENE
    • 7.2.6 ENGINEERING & HIGH-PERFORMANCE PLASTICS
      • 7.2.6.1 Polyether ether ketone
      • 7.2.6.2 Nylon/polyamide
      • 7.2.6.3 Polyphenylsulfone
      • 7.2.6.4 Polysulfones
      • 7.2.6.5 Polymethyl methacrylate
      • 7.2.6.6 Polycarbonate
      • 7.2.6.7 Acrylonitrile butadiene styrene
      • 7.2.6.8 Other Engineering & high-performance plastics
    • 7.2.7 OTHER MEDICAL PLASTICS
  • 7.3 MEDICAL ELASTOMERS
    • 7.3.1 FLEXIBILITY, DURABILITY, AND BIOCOMPATIBILITY TO DRIVE MARKET
    • 7.3.2 SILICONE
    • 7.3.3 THERMOPLASTIC ELASTOMERS
      • 7.3.3.1 Thermoplastic polyurethane
      • 7.3.3.2 Thermoplastic vulcanizates
      • 7.3.3.3 Thermoplastic styrenic elastomers
        • 7.3.3.3.1 Poly(styrene-butadiene-styrene)
        • 7.3.3.3.2 Styrene-ethylene-butylene-styrene
      • 7.3.3.4 Thermoplastic copolyester elastomers
  • 7.4 OTHER MEDICAL ELASTOMERS

8 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY

  • 8.1 INTRODUCTION
  • 8.2 EXTRUSION TUBING
    • 8.2.1 INCREASING USE IN INTRAVENOUS DELIVERY SYSTEMS, CATHETERS, AND SURGICAL INSTRUMENTS TO DRIVE MARKET
  • 8.3 COMPRESSION MOLDING
    • 8.3.1 INCREASING USE IN PROSTHETICS, ORTHOPEDIC IMPLANTS, AND DENTAL COMPONENTS TO DRIVE MARKET
  • 8.4 INJECTION MOLDING
    • 8.4.1 INCREASING USE OF SYRINGES, SURGICAL INSTRUMENTS, AND IMPLANTABLE DEVICES TO DRIVE MARKET
  • 8.5 OTHER MANUFACTURING TECHNOLOGIES

9 MEDICAL POLYMER MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 MEDICAL DISPOSABLES
    • 9.2.1 INCREASING DEMAND FOR CATHETERS AND SYRINGES TO DRIVE MARKET
    • 9.2.2 GLOVES
    • 9.2.3 SYRINGES
    • 9.2.4 MEDICAL BAGS
    • 9.2.5 OTHER MEDICAL DISPOSABLES
  • 9.3 MEDICAL INSTRUMENTS & DEVICES
    • 9.3.1 INCREASING SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET
    • 9.3.2 MEDICAL TUBES
    • 9.3.3 CATHETERS
    • 9.3.4 DRUG DELIVERY INSTRUMENTS
    • 9.3.5 OTHER MEDICAL INSTRUMENTS & DEVICES
  • 9.4 PROSTHETICS
    • 9.4.1 RISING DEMAND FOR ADVANCED LIMB PROSTHESES AND IMPLANTS TO DRIVE MARKET
    • 9.4.2 IMPLANTS
    • 9.4.3 LIMB PROSTHESIS
    • 9.4.4 OTHER PROSTHETICS APPLICATIONS
  • 9.5 DIAGNOSTIC INSTRUMENTS & TOOLS
    • 9.5.1 INCREASING DEMAND IN SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET
    • 9.5.2 DENTAL TOOLS
    • 9.5.3 SURGICAL INSTRUMENTS
    • 9.5.4 OTHER DIAGNOSTIC INSTRUMENTS & TOOLS
  • 9.6 OTHER APPLICATIONS

10 MEDICAL POLYMER MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 High R&D investments in medical sector to drive market
    • 10.2.2 CANADA
      • 10.2.2.1 Emerging demand for dental implants to drive market
    • 10.2.3 MEXICO
      • 10.2.3.1 Expansion of manufacturing facilities to drive market
  • 10.3 ASIA PACIFIC
    • 10.3.1 CHINA
      • 10.3.1.1 Establishment of medical device manufacturing units and investment in other healthcare-related sectors to drive market
    • 10.3.2 INDIA
      • 10.3.2.1 Rapid economic growth and growing population to drive market
    • 10.3.3 SOUTH KOREA
      • 10.3.3.1 Advanced healthcare and medical technologies to boost market
    • 10.3.4 JAPAN
      • 10.3.4.1 Developments in minimally invasive treatment and robotic surgery to support market growth
    • 10.3.5 AUSTRALIA
      • 10.3.5.1 Regulatory compliance and strategic collaborations to support market growth
    • 10.3.6 REST OF ASIA PACIFIC
  • 10.4 MIDDLE EAST & AFRICA
    • 10.4.1 GCC COUNTRIES
      • 10.4.1.1 Saudi Arabia
        • 10.4.1.1.1 Surge in aging population to drive demand for medical polymers
      • 10.4.1.2 UAE
        • 10.4.1.2.1 Population growth and changing epidemiology to drive market
      • 10.4.1.3 Rest of GCC
    • 10.4.2 SOUTH AFRICA
      • 10.4.2.1 Increased government spending on healthcare to drive market
    • 10.4.3 REST OF MIDDLE EAST & AFRICA
  • 10.5 EUROPE
    • 10.5.1 GERMANY
      • 10.5.1.1 Rising demand in dental implant application to drive market
    • 10.5.2 FRANCE
      • 10.5.2.1 Aging population and sedentary lifestyle to boost demand for polymers
    • 10.5.3 UK
      • 10.5.3.1 Growing incidences of chronic diseases and government support for innovation to drive market
    • 10.5.4 ITALY
      • 10.5.4.1 Strong production facilities with presence of global players to propel market growth
    • 10.5.5 SPAIN
      • 10.5.5.1 Surge in government funding for healthcare sector to support market
    • 10.5.6 REST OF EUROPE
  • 10.6 SOUTH AMERICA
    • 10.6.1 BRAZIL
      • 10.6.1.1 Growing aging population, expanding economy, and increasing health awareness to drive market
    • 10.6.2 ARGENTINA
      • 10.6.2.1 Availability of highly trained specialists and low cost of medical services boosting medical tourism industry
    • 10.6.3 REST OF SOUTH AMERICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES
  • 11.3 REVENUE ANALYSIS, 2022-2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.6 BRAND/PRODUCT COMPARISON ANALYSIS
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.7.5.1 Company footprint
      • 11.7.5.2 Region footprint
      • 11.7.5.3 Type footprint
      • 11.7.5.4 Application footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • 11.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2024
      • 11.8.5.1 Detailed list of key startups/SMEs
      • 11.8.5.2 Competitive benchmarking of key startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

  • 12.1 MAJOR PLAYERS
    • 12.1.1 BASF
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products/Services/Solutions offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches
        • 12.1.1.3.2 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 SABIC
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products/Services/Solutions offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Deals
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses and competitive threats
    • 12.1.3 COVESTRO AG
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products/Services/Solutions offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches
        • 12.1.3.3.2 Expansions
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 CELANESE CORPORATION
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products/Services/Solutions offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Deals
        • 12.1.4.3.2 Expansions
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 EVONIK INDUSTRIES
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products/Services/Solutions offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches
        • 12.1.5.3.2 Expansions
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses and competitive threats
    • 12.1.6 ARKEMA
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products/Services/Solutions offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Product launches
        • 12.1.6.3.2 Deals
        • 12.1.6.3.3 Expansions
      • 12.1.6.4 MnM view
        • 12.1.6.4.1 Key strengths
    • 12.1.7 SOLVAY
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products/Services/Solutions offered
      • 12.1.7.3 MnM view
        • 12.1.7.3.1 Key strengths
    • 12.1.8 KURARAY CO., LTD.
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products/Services/Solutions offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Expansions
      • 12.1.8.4 MnM view
    • 12.1.9 MOMENTIVE PERFORMANCE MATERIALS INC.
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products/Services/Solutions offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Deals
        • 12.1.9.3.2 Expansions
      • 12.1.9.4 MnM view
    • 12.1.10 DUPONT
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products/Services/Solutions offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Deals
        • 12.1.10.3.2 Expansions
      • 12.1.10.4 MnM view
  • 12.2 OTHER PLAYERS
    • 12.2.1 TRINSEO
    • 12.2.2 KRATON CORPORATION
    • 12.2.3 TOTAL PLASTICS
    • 12.2.4 SIMONA AMERICA
    • 12.2.5 DSM
    • 12.2.6 INVIBIO
    • 12.2.7 AVIENT CORPORATION
    • 12.2.8 RTP COMPANY
    • 12.2.9 TEKNIPLEX
    • 12.2.10 TEKNOR APEX
    • 12.2.11 MITSUBISHI CHEMICALS ADVANCED MATERIALS
    • 12.2.12 WACKER CHIMIE
    • 12.2.13 HARDIE POLYMERS
    • 12.2.14 ELIX POLYMERS
    • 12.2.15 INNOVATIVE POLYMER COMPOUNDS

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 MEDICAL POLYMER MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 MEDICAL POLYMER MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 3 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2018-2025
  • TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS
  • TABLE 5 KEY BUYING CRITERIA IN MAJOR APPLICATIONS
  • TABLE 6 MEDICAL POLYMER MARKET: ROLE IN ECOSYSTEM
  • TABLE 7 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 MEDICAL POLYMER MARKET: CONFERENCES & EVENTS, 2025-2026
  • TABLE 12 AVERAGE SELLING PRICE OF MEDICAL POLYMER, BY REGION, 2022-2024 (USD/KG)
  • TABLE 13 AVERAGE SELLING PRICE OF MEDICAL POLYMER OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 (USD/KG)
  • TABLE 14 TOP 10 PATENT OWNERS, 2015-2024
  • TABLE 15 TABLE 1: US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 16 MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 17 MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 18 MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 19 MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 20 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (USD MILLION)
  • TABLE 21 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 22 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (KILOTON)
  • TABLE 23 MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (KILOTON)
  • TABLE 24 MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 25 MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 26 MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 27 MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 28 MEDICAL POLYMER MARKET, BY REGION, 2022-2024 (USD MILLION)
  • TABLE 29 MEDICAL POLYMER MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 30 MEDICAL POLYMER MARKET, BY REGION, 2022-2024 (KILOTON)
  • TABLE 31 MEDICAL POLYMER MARKET, BY REGION, 2025-2030 (KILOTON)
  • TABLE 32 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
  • TABLE 33 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 34 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022-2024 (KILOTON)
  • TABLE 35 NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025-2030 (KILOTON)
  • TABLE 36 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 37 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 38 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 39 NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 40 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 41 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 42 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 43 NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 44 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (USD MILLION)
  • TABLE 45 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (KILOTON)
  • TABLE 47 NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (KILOTON)
  • TABLE 48 US: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 49 US: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 50 US: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 51 US: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 52 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 53 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 54 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 55 US: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 56 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 57 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 58 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 59 CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 60 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 61 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 62 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 63 CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 64 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 65 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 66 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 67 MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 68 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 69 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 70 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 71 MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 72 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2022-2024 (KILOTON)
  • TABLE 75 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2025-2030 (KILOTON)
  • TABLE 76 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 77 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 79 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 80 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 83 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 84 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 86 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (KILOTON)
  • TABLE 87 ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (KILOTON)
  • TABLE 88 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 89 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 90 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 91 CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 92 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 93 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 94 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 95 CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 96 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 97 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 98 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 99 INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 100 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 101 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 102 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 103 INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 104 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 105 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 106 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 107 SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 108 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 109 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 110 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 111 SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 112 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 113 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 114 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 115 JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 116 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 117 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 118 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 119 JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 120 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 121 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 122 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 123 AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 124 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 125 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 126 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 127 AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 128 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 129 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 130 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 131 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 132 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 133 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 134 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 135 REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 136 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
  • TABLE 137 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 138 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022-2024 (KILOTON)
  • TABLE 139 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025-2030 (KILOTON)
  • TABLE 140 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 141 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 142 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 143 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 144 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 145 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 146 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 147 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 148 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (USD MILLION)
  • TABLE 149 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 150 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (KILOTON)
  • TABLE 151 MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (KILOTON)
  • TABLE 152 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 153 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 154 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 155 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 156 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 157 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 158 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 159 SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 160 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 161 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 162 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 163 UAE: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 164 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 165 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 166 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 167 UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 168 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 169 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 170 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 171 REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 172 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 173 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 174 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 175 REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 176 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 177 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 178 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 179 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 180 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 181 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 182 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 183 SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 184 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 185 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 186 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 187 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 188 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 189 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 190 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 191 REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 192 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
  • TABLE 193 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 194 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2022-2024 (KILOTON)
  • TABLE 195 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2025-2030 (KILOTON)
  • TABLE 196 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 197 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 198 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 199 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 200 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 201 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 202 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 203 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 204 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (USD MILLION)
  • TABLE 205 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 206 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (KILOTON)
  • TABLE 207 EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (KILOTON)
  • TABLE 208 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 209 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 210 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 211 GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 212 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 213 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 214 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 215 GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 216 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 217 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 218 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 219 FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 220 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 221 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 222 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 223 FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 224 UK: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 225 UK: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 226 UK: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 227 UK: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 228 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 229 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 230 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 231 UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 232 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 233 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 234 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 235 ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 236 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 237 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 238 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 239 ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 240 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 241 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 242 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 243 SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 244 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 245 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 246 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 247 SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 248 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 249 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 250 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 251 REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 252 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 253 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 254 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 255 REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 256 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
  • TABLE 257 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 258 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022-2024 (KILOTON)
  • TABLE 259 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025-2030 (KILOTON)
  • TABLE 260 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 261 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 262 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 263 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 264 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 265 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 266 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 267 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 268 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (USD MILLION)
  • TABLE 269 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 270 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022-2024 (KILOTON)
  • TABLE 271 SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025-2030 (KILOTON)
  • TABLE 272 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 273 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 274 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 275 BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 276 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 277 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 278 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 279 BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 280 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 281 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 282 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 283 ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 284 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 285 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 286 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 287 ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 288 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (USD MILLION)
  • TABLE 289 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 290 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022-2024 (KILOTON)
  • TABLE 291 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025-2030 (KILOTON)
  • TABLE 292 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (USD MILLION)
  • TABLE 293 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 294 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022-2024 (KILOTON)
  • TABLE 295 REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 296 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL POLYMER MARKET BETWEEN 2021 AND 2025
  • TABLE 297 MEDICAL POLYMER MARKET: DEGREE OF COMPETITION
  • TABLE 298 MEDICAL POLYMER MARKET: REGION FOOTPRINT
  • TABLE 299 MEDICAL POLYMER MARKET: TYPE FOOTPRINT
  • TABLE 300 MEDICAL POLYMER MARKET: APPLICATION FOOTPRINT
  • TABLE 301 MEDICAL POLYMER MARKET: KEY STARTUPS/SMES
  • TABLE 302 MEDICAL POLYMER MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 303 MEDICAL POLYMER MARKET: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 304 MEDICAL POLYMER MARKET: DEALS, JANUARY 2021-JULY 2025
  • TABLE 305 MEDICAL POLYMER MARKET: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 306 BASF: COMPANY OVERVIEW
  • TABLE 307 BASF: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 308 BASF: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 309 BASF: DEALS, JANUARY 2021-JULY 2025
  • TABLE 310 SABIC: COMPANY OVERVIEW
  • TABLE 311 SABIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 312 SABIC: DEALS, JANUARY 2021-JULY 2025
  • TABLE 313 COVESTRO AG: COMPANY OVERVIEW
  • TABLE 314 COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 315 COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 316 COVESTRO AG: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 317 CELANESE CORPORATION: COMPANY OVERVIEW
  • TABLE 318 CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 319 CELANESE CORPORATION: DEALS, JANUARY 2021-JULY 2025
  • TABLE 320 CELANESE CORPORATION: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 321 EVONIK INDUSTRIES: COMPANY OVERVIEW
  • TABLE 322 EVONIK INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 323 EVONIK INDUSTRIES: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 324 EVONIK INDUSTRIES: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 325 ARKEMA: COMPANY OVERVIEW
  • TABLE 326 ARKEMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 327 ARKEMA: PRODUCT LAUNCHES, JANUARY 2021-JULY 2025
  • TABLE 328 ARKEMA: DEALS, JANUARY 2021-JULY 2025
  • TABLE 329 ARKEMA: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 330 SOLVAY: COMPANY OVERVIEW
  • TABLE 331 SOLVAY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 332 KURARAY CO., LTD.: COMPANY OVERVIEW
  • TABLE 333 KURARAY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 334 KURARAY CO., LTD.: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 335 MOMENTIVE PERFORMANCE MATERIALS INC.: COMPANY OVERVIEW
  • TABLE 336 MOMENTIVE PERFORMANCE MATERIALS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 337 MOMENTIVE PERFORMANCE MATERIALS INC.: DEALS, JANUARY 2021-JULY 2025
  • TABLE 338 MOMENTIVE PERFORMANCE MATERIALS INC.: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 339 DUPONT: COMPANY OVERVIEW
  • TABLE 340 DUPONT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 341 DUPONT: DEALS, JANUARY 2021-JULY 2025
  • TABLE 342 DUPONT: EXPANSIONS, JANUARY 2021-JULY 2025
  • TABLE 343 TRINSEO: COMPANY OVERVIEW
  • TABLE 344 KRATON CORPORATION: COMPANY OVERVIEW
  • TABLE 345 TOTAL PLASTICS: COMPANY OVERVIEW
  • TABLE 346 SIMONA AMERICA: COMPANY OVERVIEW
  • TABLE 347 DSM: COMPANY OVERVIEW
  • TABLE 348 INVIBIO: COMPANY OVERVIEW
  • TABLE 349 AVIENT CORPORATION: COMPANY OVERVIEW
  • TABLE 350 RTP COMPANY: COMPANY OVERVIEW
  • TABLE 351 TEKNIPLEX: COMPANY OVERVIEW
  • TABLE 352 TEKNOR APEX: COMPANY OVERVIEW
  • TABLE 353 MITSUBISHI CHEMICALS ADVANCED MATERIALS: COMPANY OVERVIEW
  • TABLE 354 WACKER CHIMIE: COMPANY OVERVIEW
  • TABLE 355 HARDIE POLYMERS: COMPANY OVERVIEW
  • TABLE 356 ELIX POLYMERS: COMPANY OVERVIEW
  • TABLE 357 INNOVATIVE POLYMER COMPOUNDS: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MEDICAL POLYMER MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 MEDICAL POLYMER MARKET: RESEARCH DESIGN
  • FIGURE 3 MEDICAL POLYMER MARKET: BOTTOM-UP APPROACH
  • FIGURE 4 MEDICAL POLYMER MARKET: TOP-DOWN APPROACH
  • FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL POLYMER MARKET TOP-DOWN APPROACH
  • FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS
  • FIGURE 7 MEDICAL POLYMER MARKET: DATA TRIANGULATION
  • FIGURE 8 MEDICAL PLASTICS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 9 MEDICAL INSTRUMENTS & DEVICES SEGMENT TO RECORD FASTEST GROWTH DURING FORECAST PERIOD
  • FIGURE 10 EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
  • FIGURE 12 INCREASING DEMAND FROM MEDICAL INSTRUMENTS & DEVICES APPLICATION TO DRIVE MARKET DURING FORECAST PERIOD
  • FIGURE 13 MEDICAL PLASTICS SEGMENT TO LEAD MEDICAL POLYMER MARKET DURING FORECAST PERIOD
  • FIGURE 14 MEDICAL INSTRUMENTS & DEVICES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 15 EXTRUSION TUBING SEGMENT TO HOLD LARGEST SHARE DURING FORECAST PERIOD
  • FIGURE 16 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 17 MEDICAL POLYMER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18 PORTER'S FIVE FORCES ANALYSIS: MEDICAL POLYMER MARKET
  • FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS
  • FIGURE 20 KEY BUYING CRITERIA IN MAJOR APPLICATIONS
  • FIGURE 21 MEDICAL POLYMER MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 22 MEDICAL POLYMER ECOSYSTEM
  • FIGURE 23 MEDICAL POLYMER MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 24 IMPORT OF MEDICAL POLYMERS, BY COUNTRY, 2020-2024 (USD MILLION)
  • FIGURE 25 EXPORT OF MEDICAL POLYMERS, BY COUNTRY, 2020-2024 (USD MILLION)
  • FIGURE 26 AVERAGE SELLING PRICE TREND, BY REGION, 2022-2024
  • FIGURE 27 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2022-2024
  • FIGURE 28 AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, BY APPLICATION, 2024
  • FIGURE 29 INVESTMENT AND FUNDING SCENARIO, 2019-2023 (USD MILLION)
  • FIGURE 32 LEGAL STATUS OF PATENTS, 2015-2024
  • FIGURE 35 MEDICAL PLASTICS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 36 EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 37 MEDICAL INSTRUMENTS & DEVICES TO HOLD LARGEST SHARE DURING FORECAST PERIOD
  • FIGURE 38 MEDICAL POLYMER MARKET SNAPSHOT
  • FIGURE 39 NORTH AMERICA: MEDICAL POLYMER MARKET SNAPSHOT
  • FIGURE 40 ASIA PACIFIC: MEDICAL POLYMER MARKET SNAPSHOT
  • FIGURE 41 EUROPE: MEDICAL POLYMER MARKET SNAPSHOT
  • FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2022-2024
  • FIGURE 43 SHARES OF TOP FIVE COMPANIES IN MEDICAL POLYMER MARKET, 2024
  • FIGURE 44 VALUATION OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2024
  • FIGURE 45 FINANCIAL METRICS OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2024
  • FIGURE 46 MEDICAL POLYMER MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 47 MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 48 MEDICAL POLYMER MARKET: COMPANY FOOTPRINT
  • FIGURE 49 MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 50 BASF: COMPANY SNAPSHOT
  • FIGURE 51 SABIC: COMPANY SNAPSHOT
  • FIGURE 52 COVESTRO AG: COMPANY SNAPSHOT
  • FIGURE 53 CELANESE CORPORATION: COMPANY SNAPSHOT
  • FIGURE 54 EVONIK INDUSTRIES: COMPANY SNAPSHOT
  • FIGURE 55 ARKEMA: COMPANY SNAPSHOT
  • FIGURE 56 SOLVAY: COMPANY SNAPSHOT
  • FIGURE 57 KURARAY CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 58 DUPONT: COMPANY SNAPSHOT